Dean Y Li Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Dean Y Li is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.24 Million shares of RXRX, which is worth approximately $6.53 Million. The most recent transaction as insider was on Apr 16, 2021, when has been sold 13,889 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.24M
1453.12% 3M change
1576.06% 12M change
Total Value Held $6.53 Million

Dean Y Li Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2021
BUY
Grant, award, or other acquisition
-
13,889 Added 2.28%
596,390 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
Executive VP & President, MRL
DYL

Dean Y Li

Director
Kenilworth, NJ

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX